ORSI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 118
EU - Europa 111
AS - Asia 74
Continente sconosciuto - Info sul continente non disponibili 1
Totale 304
Nazione #
US - Stati Uniti d'America 116
CN - Cina 43
IT - Italia 43
SE - Svezia 33
SG - Singapore 26
RU - Federazione Russa 16
DE - Germania 4
IN - India 4
FI - Finlandia 3
IE - Irlanda 3
AL - Albania 2
CA - Canada 2
NL - Olanda 2
BE - Belgio 1
EU - Europa 1
FR - Francia 1
GB - Regno Unito 1
HK - Hong Kong 1
HR - Croazia 1
LT - Lituania 1
Totale 304
Città #
Singapore 17
Shanghai 16
Ashburn 15
Boardman 14
Milan 14
New York 10
Lawrence 7
Princeton 7
Moscow 6
Carlsbad 5
Seattle 4
Turin 4
Beijing 3
Brescia 3
Dallas 3
Dublin 3
Hyderabad 3
Rome 3
Berlin 2
Bolzano 2
Buffalo 2
Cuneo 2
Guangzhou 2
Guiyang 2
Helsinki 2
Modena 2
New Haven 2
Ottawa 2
Reggio Emilia 2
San Maurizio Canavese 2
Tirana 2
Verdellino 2
Amsterdam 1
Borgomanero 1
Brussels 1
Chongqing 1
Fort Worth 1
Frankfurt am Main 1
Fuzhou 1
Hong Kong 1
Jiaxing 1
Lappeenranta 1
Los Angeles 1
Lu'an 1
Pisa 1
Pune 1
San Martino Buon Albergo 1
Shaoxing 1
Shenzhen 1
St Petersburg 1
Washington 1
Weitang 1
Zhongshan 1
Totale 186
Nome #
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapy 25
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 25
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 24
The impact of nutritional status on pancreatic cancer therapy 23
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey 18
Extensive molecular reclassification: new perspectives in small bowel adenocarcinoma? 18
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index 17
Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocarcinoma 16
Treatment opportunities and future perspectives for pancreatic cancer patients with germline BRCA1-2 pathogenic variants 16
Epidemiology and geographic distribution of BRCA1-2 and DNA Damage response genes pathogenic variants in pancreatic ductal adenocarcinoma patients 16
Cyclophosphamide maintenance to extend combination chemotherapy-free interval in metastatic pancreatic ductal adenocarcinoma 15
Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes 14
Isolated lung metastases from pancreatic ductal adenocarcinoma (PDAC): Diagnostic and therapeutic challenges of a different disease 13
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey 13
Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma 13
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 12
Lessons and open questions in borderline resectable pancreatic cancer 11
Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrence 11
Pancreatic cancer: still a cold case? 11
Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples 11
Is the Delphi's Oracle Pertinent to Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma? 11
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv) 10
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 8
Endoscopic ultrasound-guided choledochoduodenostomy versus hepaticogastrostomy combined with gastroenterostomy in malignant double obstruction (CABRIOLET_Pro): A prospective comparative study 3
Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients 1
Totale 355
Categoria #
all - tutte 4.624
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.624


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20229 0 0 0 0 0 0 0 5 3 0 0 1
2022/202368 14 11 5 0 1 16 3 10 2 0 6 0
2023/2024157 12 9 12 31 15 18 5 15 4 10 5 21
2024/2025121 39 11 19 22 29 1 0 0 0 0 0 0
Totale 355